glp-1 obesity drug news october 2025 The Obesity-Drug Revolution Is Stalling GLP-1 Pipeline Update: August 2025
Description
Global Economic Burden of Diabetes in Adults: Projections From 2015 to 2030
GLP-1 Elicits an Intrinsic Gut-Liver Metabolic Signal to Ameliorate Diet-Induced VLDL Overproduction and Insulin Resistance
maintaining hydration is essential
[138] In April 2025, the Trump Administration declined to finalize a proposal from the Biden Administration that would have required Medicare, Medicaid, and CHIP to broadly cover GLP-1s for weight loss
Lancet 2023;402:472-83
GLP-1 agonist drugs, often called GLP-1s, are injectable medications that work by mimicking the GLP-1 hormone that your small intestine makes in response to food
